The findings of our research corroborate the notion that CD320 is intricately linked to tumor angiogenesis, as our angiogenesis experiments demonstrated a significant reduction in the angiogenesis capacity of endothelial cells following the knockdown of CD320. Here, CD320 is linked to neoplasm.